What does CUSIP 29664WAB1 represent in this 13F holders report?

CUSIP 29664WAB1 is the security identifier for 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 used to aggregate holder disclosures.

How many institutions held 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in Q4 2025?

No institutional holders were reported for 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in Q4 2025; review adjacent reporting periods for trend context.

ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

CUSIP: 29664WAB1

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Debt / NOTE 4.000%11/1
Total 13F principal: $0
Principal change: -$28,696,440
Total reported market value: $0
Number of holders: 0
Value change: -$40,994,280
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 29664WAB1?
CUSIP 29664WAB1 identifies 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2025

Recent filing periods for CUSIP 29664WAB1:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1

Q4 2025 13F Holders as of 31 Dec 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q4 2025.